Bill

Bill > S3557


US S3557

US S3557
A bill to require the Secretary of Health and Human Services to prepare a report that outlines a plan for completing a review of approved opioid analgesic drugs that considers the public health effects of such opioid drugs.


summary

Introduced
12/19/2023
In Committee
12/19/2023
Crossed Over
Passed
Dead
01/03/2025

Introduced Session

118th Congress

Bill Summary

A bill to require the Secretary of Health and Human Services to prepare a report that outlines a plan for completing a review of approved opioid analgesic drugs that considers the public health effects of such opioid drugs.

AI Summary

This bill requires the Secretary of Health and Human Services (HHS) to publish a report outlining a plan for reviewing approved opioid analgesic drugs. The report will consider the public health effects of these opioid drugs as part of the benefit-risk assessment, and it will address the Food and Drug Administration's (FDA) activities related to increasing the development of non-addictive medical products intended to treat pain or addiction. The report will include opportunities for public input, updates on the FDA's actions to review opioid analgesic drugs, a timeline for potential labeling changes or other actions, and an overview of the FDA's efforts to support the development and approval of non-addictive products for pain or addiction treatment.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 12/19/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...